Risk of cancer among hispanics with AIDS compared with the general population in Puerto Rico: 1987-2003

Puerto Rico Health Sciences Journal

Volumn 29, Issue 3, 2010, Pages 256-264

  Ramírez Marrero, Farah A ^a   Smit, Ellen ^b   de la Torre Feliciano, Taína ^c   Pérez Irizarry, Javier ^c   Miranda, Sandra ^d   Cruz, Maritza ^d   Figueroa Vallés, Nayda R ^c   Crespo, Carlos J ^e   Nazario, Cruz M ^f  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b OREGON STATE UNIVERSITY   (United States)

^c Puerto Rico Central Cancer Registry ^*

^d Puerto Rico AIDS Surveillance Program   (Puerto Rico)

^e PORTLAND STATE UNIVERSITY   (United States)

^f UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Acquired immune deficiency syndrome; Hispanics; Malignancies

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HISPANIC; HUMAN; MALE; MIDDLE AGED; NEOPLASM; PUERTO RICO; RISK FACTOR; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PUERTO RICO; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 77956993421     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Franceschi S, Dal Maso L, Pezzotti P, Polesel J, Braga C, Piselli P, Serraino D, Tagliabue G, Federico M, Ferretti S, De Lisi V, La Rosa F, Conti E, Budroni M, Vicario G, Piffer S, Pannelli F, Giacomin A, Bellu F, Tumino R, Fusco M, Rezza G. Incidence of AIDS-defining cancers after AIDS di- agnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr 2003;34: 84-90.
2. Franceschi S, Maso LD, Rickenbach M, Polesel J, Hirschel B, Cavassini M, Bordoni A, Elzi L, Ess S, Jundt G, Mueller N, Clifford GM. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer 2008;99: 800-804.
3. Mbulaiteye SM, Parkin DM, Rabkin CS. Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 2003; 17: 673-696.
4. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ. Trends in cancer risk among people with AIDS in the United States 1980-2002. Aids 2006;20: 1645-1654.
5. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008;148: 728-736.
6. Biggar RJ. AIDS-related cancers in the era of highly active antiretroviral therapy. Oncology (Williston Park) 2001;15: 439-448.
7. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 2001;37: 1188-1201.
8. Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. Aids 2002;16: 1155-1161.
9. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA. Spectrum of cancers among HIVinfected persons in Africa: The Uganda AIDS-Cancer Registry Match Study. Int J Cancer 2006;118: 985-990.
10. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001;154: 544-556.
11. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS 1999 May 7;13(7): 839-843.
12. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ. Spectrum of AIDS-associated malignant disorders. Lancet 1998;351: 1833-1839.
13. Biggar RJ, Burnett W, Mikl J, Nasca P. Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 1989;43: 979-985.
14. Engels EA, Goedert JJ. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: Past, present, and future. J Natl Cancer Inst 2005;97: 407-409.
15. CDC. HIV/AIDS among Hispanics. National Center for HIV, STD, and TB Prevention, Divisions of HIV/AIDS prevention.11-16-2004, 2-7- 2005.
16. O'Brien K, Cokkinides V, Jemal A, Cardinez CJ, Murray T, Samuels A, Ward E, Thun MJ. Cancer statistics for Hispanics, 2003. CA Cancer J Clin 2003;53: 208-226.
17. Levine AM. AIDS-related lymphoma. Semin Oncol Nurs 2006;22: 80-89.
18. Fordyce EJ, Wang Z, Kahn AR, Gallagher BK, Merlos I, Ly S, Schymura M, Chiasson MA. Risk of cancer among women with AIDS in New York City. AIDS Public Policy J 2000;15: 95-104.
19. Mayor AM, Gomez MA, Rios-Olivares E, Hunter-Mellado RF. AIDSdefining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy. Ethn Dis 2008;18(2 Suppl 2): S2-189-194.
20. Baez-Feliciano DV, Thomas JC, Gomez MA, Miranda S, Fernandez DM, Velazquez M, Rios-Olivares E, Hunter-Mellado RF. Changes in the AIDS epidemiologic situation in Puerto Rico following health care reform and the introduction of HAART. Rev Panam Salud Publica 2005;17: 92-101.
21. Perez-Perdomo R, Perez-Cardona CM, Suarez-Perez E. The epidemiology of tuberculosis in patients with AIDS in Puerto Rico: Morbidity and survival, 1981-1998. Int J Tuberc Lung Dis 2000;4: 713-718.
22. Perez-Perdomo R, Perez-Cardona CM, Suarez-Perez EL. Epidemiology of pediatric AIDS in Puerto Rico: 1981-1998. AIDS Patient Care STDS 1999;13: 651-658.
23. Perez-Perdomo R, Suarez-Perez EL, Perez-Cardona CM. Epidemiologic profile of AIDS among Puerto Rican women in the San Juan Standard Metropolitan Statistical Area, 1981-1995. Cell Mol Biol (Noisy-le-grand) 1997;43: 1131-1138.
24. Centers for Disease Control and Prevention. National Program of Cancer Registries: Technical Assistance and Audit Puerto Rico Central Cancer Registry, Case Completeness and Data Quality Audit. Atlanta: 2003.
25. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19: 335-351.
26. Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Aids 2008;22: 301-306.
27. Perez CM, Suarez E, Torres EA. Epidemiology of hepatitis C infection and its public health implications in Puerto Rico. P R Health Sci J 2004;23(2 Suppl): 11-28.
28. El Amari EB, Toutous-Trellu L, Gayet-Ageron A, Baumann M, Cathomas G, Steffen I, Erb P, Mueller NJ, Furrer H, Cavassini M, Vernazza P, Hirsch HH, Bernasconi E, Hirschel B. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. Aids 2008;22: 1019-1028.
29. Schollkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Panum I, Vinner L, Chang ET, Glimelius B, Porwit A, Sundstrom C, Hansen M, Adami HO, Melbye M. Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008;122: 1885-1890.
30. Phelan DF, Gange SJ, Ahdieh-Grant L, Mehta SH, Kirk GD, Shah K, Gravitt P. Determinants of Newly Detected Human Papillomavirus Infection in HIV-Infected and HIV-Uninfected Injection Drug Using Women. Sex Transm Dis 2009 Feb 9 (Epub ahead of print].
31. Videla S, Darwich L, Canadas MP, Paredes R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology. J Acquir Immune Defic Syndr 2009;50: 168-175.
32. Mangclaviraj S, Kerr SJ, Chaithongwongwatthana S, Ananworanich J, Hirschel B, Emery S, Cooper DA, Chotnopparatpattara P, Ruxrungtham K, Phanuphak P. Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting. Int J STD AIDS 2008;19: 529-532.
33. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009;52: 611-622.
34. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, Munoz N, Schiffman M, Bosch FX. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; Suppl 10: K17-28.
35. Monk BJ, Tewari KS. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol 2007;107(2 Suppl 1): S6-13.
36. Verma V, Shen D, Sieving PC, Chan CC. The role of infectious agents in the etiology of ocular adnexal neoplasia. Surv Ophthalmol 2008;53: 312-331.
37. Monto A, Currie S, Wright TL. Liver disease in injection drug users with hepatitis C, with and without HIV coinfection. J Addict Dis 2008;27: 49-59.